The Brazilian Journal of Infectious Diseases

ISSN: 1413-8670

The Brazilian Journal of Infectious Diseases is the official publication of the Brazilian Society of Infectious Diseases (SBI). It aims to publish relevant articles in the broadest sense on all aspects of microbiology, infectious diseases and immune response to infectious agents.
The BJID is a bimonthly publication and one of the most influential journals in its field in Brazil and Latin America with a high impact factor. Since its inception it has garnered a growing share of the publishing market.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

Most cited

High prevalence of hepatitis A and E viruses in environmental and clinical samples from West Argentina

Ivana Lo Castro, Carlos Espul, Vanessa Salete de Paula, Nancy R. Altabert, Jorge E. Gonzalez, Barbara Vieira Lago, Livia Melo Villar

Braz J Infect Dis. 2023;27:102738

Full text access

Twitter

Facebook

Rapid bacterial identification by MALDI-TOF MS directly from blood cultures and rapid susceptibility testing: A simple approach to reduce the turnaround time of blood cultures

Patricia Orlandi Barth, Eliane Wurdig Roesch, Larissa Lutz, Ândrea Celestino de Souza, Luciano Zubaran Goldani, Dariane Castro Pereira

Braz J Infect Dis. 2023;27:102721

Full text access

Twitter

Facebook

Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study

Veena Sreedharan, K.V. Bhaskara Rao

Braz J Infect Dis. 2023;27:102739

Full text access

Twitter

Facebook

The first case of acute HIV and monkeypox coinfection in Latin America

Mayara Secco Torres Silva, Desiree Gomes dos Santos, Carolina Coutinho, Maria Pia Diniz Ribeiro, Sandra Wagner Cardoso, Valdilea Gonçalves Veloso, Beatriz Grinsztejn

Braz J Infect Dis. 2023;27:102736

Full text access

Twitter

Facebook

Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials

Elahe Akbari, Masoud Seyedinkhorasani, Azam Bolhassani

Braz J Infect Dis. 2023;27:102774

Full text access

Twitter

Facebook

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

Mark G. Wise, James A. Karlowsky, Elkin V. Lemos-Luengas, Rafael R. Valdez, Daniel F. Sahm

Braz J Infect Dis. 2023;27:102759

Full text access

Twitter

Facebook

Long-term assessment of systemic microcirculatory function and plasma cytokines after coronavirus disease 2019 (COVID-19)

Letícia Sabioni, Andrea De Lorenzo, Hugo Caire Castro-Faria-Neto, Vanessa Estato, Eduardo Tibirica

Braz J Infect Dis. 2023;27:102719

Full text access

Twitter

Facebook

Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil

Amanda Echeverría-Guevara, Lara E. Coelho, Valdiléa G. Veloso, Maria C. Pimenta, Brenda Hoagland, Ronaldo I. Moreira, Iuri Leite, Emília M. Jalil, ... Beatriz Grinsztejn

Braz J Infect Dis. 2023;27:102733

Full text access

Twitter

Facebook

Nocardiosis: a single-center experience and literature review

Bruno Besteiro, Daniel Coutinho, Joana Fragoso, Cristóvão Figueiredo, Sofia Nunes, Carlos Azevedo, Tiago Teixeira, Aurélia Selaru, ... Luís Malheiro

Braz J Infect Dis. 2023;27:102806

Full text access

Twitter

Facebook

Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia

Ana Paula Schonardie, Eduarda Beck, Maria Helena Rigatto